Literature DB >> 22579962

A novel serine protease with human fibrino(geno)lytic activities from Artocarpus heterophyllus latex.

Jaruwan Siritapetawee1, Kanjana Thumanu, Punchapat Sojikul, Sompong Thammasirirak.   

Abstract

A protease was isolated and purified from Artocarpus heterophyllus (jackfruit) latex and designated as a 48-kDa antimicrobial protease (AMP48) in a previous publication. In this work, the enzyme was characterized for more biochemical and medicinal properties. Enzyme activity of AMP48 was strongly inhibited by phenylmethanesulfonyl fluoride and soybean trypsin inhibitor, indicating that the enzyme was a plant serine protease. The N-terminal amino acid sequences (A-Q-E-G-G-K-D-D-D-G-G) of AMP48 had no sequence similarity matches with any sequence databases of BLAST search and other plant serine protease. The secondary structure of this enzyme was composed of high α-helix (51%) and low β-sheet (9%). AMP48 had fibrinogenolytic activity with maximal activity between 55 and 60°C at pH 8. The enzyme efficiently hydrolyzed α followed by partially hydrolyzed β and γ subunits of human fibrinogen. In addition, the fibrinolytic activity was observed through the degradation products by SDS-PAGE and emphasized its activity by monitoring the alteration of secondary structure of fibrin clot after enzyme digestion using ATR-FTIR spectroscopy. This study presented the potential role to use AMP48 as antithrombotic for treatment thromboembolic disorders such as strokes, pulmonary emboli and deep vein thrombosis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579962     DOI: 10.1016/j.bbapap.2012.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Hemostatic potential of latex proteases from Tabernaemontana divaricata (L.) R. Br. ex. Roem. and Schult. and Artocarpus altilis (Parkinson ex. F.A. Zorn) Forsberg.

Authors:  Maheshwari Kumari Singh; R Usha; K R Hithayshree; O S Bindhu
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

Review 3.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Proteases from Canavalia ensiformis: Active and Thermostable Enzymes with Potential of Application in Biotechnology.

Authors:  Rayane Natshe Gonçalves; Suellen Duarte Gozzini Barbosa; Raquel Elisa da Silva-López
Journal:  Biotechnol Res Int       Date:  2016-08-17

Review 5.  A critical review on serine protease: Key immune manipulator and pathology mediator.

Authors:  S Patel
Journal:  Allergol Immunopathol (Madr)       Date:  2017-02-21       Impact factor: 1.667

Review 6.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

7.  Purification, characterization and fibrino(geno)lytic activity of cysteine protease from Tabernaemontana divaricata latex.

Authors:  Maheshwari Kumari Singh; Anusha Rajagopalan; Habibu Tanimu; Bindhu Omana Sukumaran
Journal:  3 Biotech       Date:  2021-01-31       Impact factor: 2.406

Review 8.  Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy.

Authors:  Farwa Altaf; Shourong Wu; Vivi Kasim
Journal:  Front Mol Biosci       Date:  2021-05-28

9.  Hemostatic, milk clotting and blood stain removal potential of cysteine proteases from Calotropis gigantea (L.) R. Br. Latex.

Authors:  Omana Sukumaran Bindhu; Maheshwari Kumari Singh
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.